Results 151 to 160 of about 6,152 (197)

Crystallization and Preliminary X-Ray Diffraction Studies of Guanidinoacetate Methyltransferase From Rat Liver [PDF]

open access: yesActa Crystallographica Section D: Biological Crystallography, 1999
This is the publisher's version, also available electronically from http://scripts.iucr.org/cgi-bin/paper?S0907444999010318.Guanidinoacetate methyltransferase is the enzyme which catalyzes the last step of creatine biosynthesis.
Fusao Takusagawa   +2 more
exaly   +2 more sources

Catalytic Mechanism of Guanidinoacetate Methyltransferase:  Crystal Structures of Guanidinoacetate Methyltransferase Ternary Complexes,

Biochemistry, 2004
Guanidinoacetate methyltransferase (GAMT) is the enzyme that catalyzes the last step of creatine biosynthesis. The enzyme is found in abundance in the livers of all vertebrates. The intact GAMT from recombinant rat liver has been crystallized with an inhibitor S-adenosylhomocysteine (SAH) and a substrate guanidinoacetate (GAA), and with SAH and an ...
Junichi, Komoto   +7 more
openaire   +2 more sources

Impaired Metabolism of Guanidinoacetic Acid in Uremia

Nephron, 2008
In order to investigate the guanidinoacetic acid (GAA) metabolism in uremia, we have measured serum guanidino compounds in patients with chronic renal failure (CRF) in comparison with normal subjects, and the renal content of GAA and glycine amidinotransferase (GAT) activity in the kidney of experimental CRF rabbits.
Y, Tofuku   +3 more
openaire   +2 more sources

Guanidinoacetate methyltransferase deficiency (GAMT)

Brain and Development, 2010
An increasing number of disorders of metabolism are becoming amenable to the treatment, and GAMT deficiency is one of them. The symptoms and signs are reviewed, emphasising that delayed language development is a particular feature. Other symptoms include learning disorders, autistic behaviour, epileptic seizures, and movement disorders.
openaire   +2 more sources

Advanced physiological roles of guanidinoacetic acid

European Journal of Nutrition, 2015
Dietary guanidinoacetic acid (GAA) seems to improve cellular bioenergetics by stimulating creatine biosynthesis. However, GAA could have other biological functions that might affect its possible use as a food ingredient in human nutrition. In this paper, we identified several alternative physiological roles of supplemental GAA, including the ...
openaire   +2 more sources

Guanidinoacetic acid as a performance-enhancing agent

Amino Acids, 2015
Guanidinoacetic acid (GAA; also known as glycocyamine or guanidinoacetate) is the natural precursor of creatine, and under investigation as a novel dietary agent. It was first identified as a natural compound in humans ~80 years ago. In the 1950s, GAA's use as a therapeutic agent was explored, showing that supplemental GAA improved patient-reported ...
openaire   +2 more sources

A new enzymatic assay of urinary guanidinoacetic acid

Clinica Chimica Acta, 1991
We describe a new enzymatic determination of urinary guanidinoacetic acid (GAA) with guanidinoacetate kinase (ATP: guanidinoacetate N-phosphotransferase, EC 2.7.3.1), which does not require a blank to correct for endogenous constituents (ADP and pyruvate).
Y, Shirokane, M, Nakajima, K, Mizusawa
openaire   +2 more sources

Epileptic and electroencephalographic manifestations of guanidinoacetate‐methyltransferase deficiency

Epileptic Disorders, 2013
ABSTRACT Aim. Describe the seizure‐related manifestations of guanidinoacetate methyltransferase (GAMT) deficiency in two new cases and compare these to the related literature. Methods. We reviewed the clinical and electroencephalographic manifestations of
Abdul G, Mikati   +4 more
openaire   +2 more sources

Guanidinoacetate methyltransferase deficiency: New clinical features

Pediatric Neurology, 1997
Guanidinoacetate methyltransferase deficiency is a recently described inborn error of creatine biosynthesis that responds to treatment with oral creatine supplementation. The previously reported clinical features consist of developmental arrest and an extrapyramidal movement disorder.
V, Ganesan   +4 more
openaire   +2 more sources

Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency

Neurology, 2006
Prospective observation in a neonate with guanidinoacetate methyltransferase deficiency (GAMT-D), a severe neurometabolic disorder, revealed increased guanidinoacetate levels at birth. After 14-month treatment with creatine, high-dose ornithine, benzoate, and an arginine-restricted diet, the patient's development is normal and she does not present any ...
A, Schulze   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy